Company: INTS
Filing Date: 2025-06-06
Form Type: 8-K
Source: 0001567264-25-000056
Chunk: 1

Company: INTENSITY THERAPEUTICS, INC.
Filing Date: 2025-06-06
Form: 8-K
Item: Item 3.01
Chunk 1
---
daq will grant the Company a further extension of time to regain compliance, if applicable.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: June 6, 2025

  Intensity Therapeutics, Inc.                                                        
  By:                               /s/ Lewis H. Bender                               
                                    Name:                    Lewis H. Bender          
                                    Title:                   Chief Executive Officer  

[Signature Page to the Form 8-K]